新癌症研究論文發表~"PI3K Inhibitor Enhances the Cytotoxic Response to Etoposide and Cisplatin in a Newly Established Neuroendocrine Cervical Carcinoma Cell Line" has been accepted for publication in Oncotarget.
"PI3K Inhibitor Enhances the Cytotoxic Response to Etoposide and Cisplatin in a Newly Established Neuroendocrine Cervical Carcinoma Cell Line" has been accepted for publication in Oncotarget.
